Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC8 | Q9BY41 | 16/20 | 1.00 |
| ▸ | HDAC3 | O15379 | 4/20 | 1.00 |
| ▸ | HDAC1 | Q13547 | 4/20 | 1.00 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 1.00 |
| ▸ | HDAC2 | Q92769 | 4/20 | 0.59 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.59 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.59 |
| ▸ | HDAC7 | Q8WUI4 | 2/20 | 0.59 |
| ▸ | HDAC10 | Q969S8 | 2/20 | 0.59 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.59 |
| ▸ | HDAC9 | Q9UKV0 | 2/20 | 0.59 |
| ▸ | HDAC5 | Q9UQL6 | 2/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16516543 | 1.00 | HDAC8 (1.00) | HDAC8HDAC3HDAC1NCOR2HDAC2 | |
| SCHEMBL16516669 | 0.97 | HDAC8 (1.00) | HDAC8HDAC3HDAC1NCOR2HDAC2 | |
| SCHEMBL16516440 | 0.93 | HDAC8 (1.00) | HDAC8HDAC3HDAC1NCOR2HDAC2 | |
| SCHEMBL16516242 | 0.91 | HDAC8 (1.00) | HDAC8HDAC3HDAC1NCOR2HDAC2 | |
| SCHEMBL16516633 | 0.89 | HDAC8 (1.00) | HDAC8HDAC3HDAC1NCOR2HDAC2 | |
| SCHEMBL21507724 | 0.88 | HDAC8 (0.78) | HDAC8HDAC3HDAC1NCOR2HDAC2 | |
| SCHEMBL3292153 | 0.87 | HDAC8 (0.81) | HDAC8HDAC3HDAC1NCOR2HDAC2 | |
| SCHEMBL3292152 | 0.87 | HDAC8 (0.81) | HDAC8HDAC3HDAC1NCOR2HDAC2 | |
| SCHEMBL16516589 | 0.85 | HDAC8 (0.74) | HDAC8HDAC3HDAC1NCOR2HDAC2 | |
| SCHEMBL5993526 | 0.84 | HDAC8 (0.76) | HDAC8HDAC3HDAC1NCOR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025059442-A1 | MODULATING PLANT RESPONSES TO STRESS AND GROWTH WITH CHEMICALS | REMOTE EPIGENETICS INC. (US) | 2025-03-20 | — | — | WO | claimed |
| EP-4410284-A1 | COMPOUND AND METHOD FOR THE TREATMENT OF ZELLWEGER SPECTRUM DISORDER | Apteeus (FR) | 2024-08-07 | — | — | EP | claimed |
| WO-2026107052-A1 | COMBINATION TREATMENTS USING EPIGENETIC INHIBITION AND SYNGRI-MEDIATED FRATAXIN EXPRESSION | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. (US) | 2026-05-21 | — | — | WO | disclosed |
| WO-2025059442-A1 | MODULATING PLANT RESPONSES TO STRESS AND GROWTH WITH CHEMICALS | REMOTE EPIGENETICS INC. (US) | 2025-03-20 | — | — | WO | disclosed |
| WO-2025053994-A1 | SMALL MOLECULE ENHANCERS OF SECRETED CLUSTERIN (SCLU) | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-03-13 | — | — | WO | disclosed |
| WO-2024160990-A1 | COMPOUNDS AND METHOD FOR THE TREATMENT OF ZELLWEGER SPECTRUM DISORDER | APTEEUS (FR) | 2024-08-08 | — | — | WO | disclosed |
| EP-4410284-A1 | COMPOUND AND METHOD FOR THE TREATMENT OF ZELLWEGER SPECTRUM DISORDER | Apteeus (FR) | 2024-08-07 | — | — | EP | disclosed |
| CN-116510024-A | Composition, preparation method and application thereof | 上海复东生物医药有限责任公司 | 2023-08-01 | — | — | CN | disclosed |